Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis
Clinical trial NCT02245867 · COMPLETED
Trial details
- NCT number
- NCT02245867
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-30
- Primary completion
- 2017-07-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.